Tumor Genomics to Combat Diabetes: Rare Benign Tumors May Hold the Key
An extraordinary array of new and validated pathways for diabetes treatment now possible due to recent research into tumor genomics and diabetes.
Superiority Not Proven for Rapid-acting Insulin Analogues in Type 1 Diabetes
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1.
Study: Drug Improves Glycemic Control Significantly in Type 1 Diabetics on Insulin
Results portend first major advance for type 1 diabetics since insulin was discovered. New study shows that liraglutide reduces the wide swings in blood glucose numbers that characterize even well-controlled type 1 diabetes.
New Treatment Using Skin Cells Could Replace Insulin Shots
Stem cells from diabetic patients have been coaxed to become insulin-secreting cells which would replace the need for insulin shots. Researchers have produced insulin-secreting cells...
New Insulin Pill to Replace Daily Injections Developed
Insulin pill for diabetes created by Harvard researchers. This oral insulin delivery method dramatically transforms the way diabetics keep their blood sugar levels in check.
Study: Leptin Therapy Shows Promise For Type 1 Diabetes
Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.
Breakthrough Will Help Stem Cell Researchers Develop New Type 1 Diabetes Therapies and More
New understanding, say researchers, will help spur advancements in stem cell research and the development of new cell therapies for diseases of the liver...
Study: Nerve Damage Precedes Diabetic Retinopathy
New findings about the development of diabetic retinopathy represents a shift in the long-term understanding of these diabetes complications. A University of Iowa-led study of...
Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/Galactose/Oral Xylose-Containing Products
Potential for life-threatening falsely elevated glucose readings in patients who have received parenteral products containing maltose or galactose, or oral xylose, and are subsequently tested using glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) based glucose monitoring systems.
New Skin Patch Drug Shows Promise in Healing Diabetic Foot Ulcers and Preventing Amputations
A research team has developed a drug delivered through a skin patch that not only helps foot wounds heal better, but also prevents those wounds from recurring
Diabetic Enteropathy Cause, Treatment and Possible Prevention Discovered
Diabetic enteropathy - with gastrointestinal symptoms like abdominal pain, bloating and nausea - may soon be preventable and treatable. Exciting news considering that it...
Joslin Launches Program To Bring Vision Resources To Local Communities
Joslin Diabetes Center has launched a new affiliation program designed to bring Joslin's world-class vision resources to local communities across the United States and beyond.
Scientists Make Major Finding on Potential Cure for Type 1 Diabetes
A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made.
Standard Long-Acting Insulin as Good as Newer Medications
An older type of long-acting insulin is as effective in treating type 2 diabetes as newer and more expensive kinds. However, the newer medications may cause fewer problems with low blood glucose while patients are sleeping.
Insulin Shock: Insulin Costs Tripled Over Last 10 years
Dramatic rise in insulin costs when compared with other diabetes therapies means it's time to look again at the effect, and the cost-effectiveness, of...
Difficulty Trusting and Reaching Out to Others May Shorten Diabetes Patients’ Lives
Self-reliant diabetes patients had a 33 percent higher mortality rate during a 5-year study, compared to diabetes patients who interacted easily with others and sought support.
